Access to Innovative Medicines: Regulation Change and Factors Associated with Drug Approval Lag in Malaysia
BackgroundDrug approval lag is the time difference for new medicine to obtain marketing authorization approval in the study country compared to the first global approval. Drug approval lag delays the availability of innovative medicine to patients. This may lead to delay in treatment and severe publ...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Published: |
SAGE Publications
2024
|
| Subjects: | |
| Online Access: | http://eprints.um.edu.my/45589/ https://doi.org/10.1007/s43441-024-00620-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | Universiti Malaya |